Learn More
Medchemexpress LLC 1-(2-bromophenyl)-3-(7-cyano-2H-benzotriazol-4-yl)urea | 211096-49-0 | MFCD09971124 | 699.0% | 357.16 g·mol⁻¹ | C14H9BrN6O | 10 MG

Supplier: Medchemexpress LLC HY5068810MG
SB-265610 is a selective, competitive, nonpeptide, allosteric antagonist of the CXCR2 chemokine receptor used as a research reagent to study neutrophil chemotaxis and CXCR2-mediated signaling. It inhibits CINC-1-induced calcium mobilization (IC50 3.7 nM) and neutrophil chemotaxis (IC50 70 nM).
- Selective CXCR2 antagonist for receptor pharmacology studies.
- Reported low-nanomolar potency for calcium mobilization assays.
- Suitable for in vitro chemotaxis and signaling experiments.
- Supplied as a small-molecule solid for formulation or dosing control.
- Characterized by published analytical data and CAS registration for traceability.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.